Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 11.38% is 36% above its 5-year average of 8.39%, around the middle of its 5-year range (0.00%–17.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.56% below its 12-month average of 11.68%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.38%.
DEBT TO ASSETS RATIO
11.38%
DEBT TO ASSETS RATIO AVG TTM
11.68%
DEBT TO ASSETS RATIO AVG 3Y
11.39%
DEBT TO ASSETS RATIO AVG 5Y
8.39%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.56%
CURRENT VS 3Y AVG
-0.04%
CURRENT VS 5Y AVG
+35.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+12546.03%
vs the sector median at left
PepGen Inc.
Market Cap
$159.78M
Debt to Assets Ratio
11.38%
TTM Avg
11.68%
3Y Avg
11.39%
5Y Avg
8.39%
Market Cap
$159.80M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$159.14M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$162.04M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $159.78M | 11.38% | 11.68% | 11.39% | 8.39% |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | 0.00% | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 0.10% | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | 0.20% | N/A | N/A | N/A |
| Quanterix Corporation (QTRX)vs › | $162.04M | 0.10% | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.22M | 0.06% | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $165.27M | 0.22% | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 0.12% | N/A | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $153.79M | 0.66% | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | 0.89% | N/A | N/A | N/A |
Debt/Assets
11.4%
Debt/Equity
0.13
Current Ratio
13.36
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 11.38% |
| 2026-03-31 | 10.60% |
| 2025-12-31 | 9.78% |
| 2025-09-30 | 9.18% |
| 2025-06-30 | 17.47% |
| 2025-03-31 | 14.34% |
| 2024-12-31 | 12.37% |
| 2024-09-30 | 11.18% |
| 2024-06-30 | 10.03% |
| 2024-03-31 | 9.55% |
| 2023-12-31 | 14.05% |
| 2023-09-30 | 12.44% |
| 2023-06-30 | 11.73% |
| 2023-03-31 | 10.86% |
| 2022-12-31 | 11.28% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
